Y-mAbs Therapeutics Inc (NASDAQ:YMAB)
| 5.22 Delayed Data As of Sep 22 |  +0.13 / +2.55%Today’s Change | 2.70 Today|||52-Week Range 15.89 | +6.97% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Assets | Cash | 16.9M | 90.5M | 147.9M | -- | |
| Short Term Investment Cash | 7.8M | 73.6M | 57.4M | -- | ||
| Cash & Short Term Investments | 16.9M | 90.5M | 147.9M | -- | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | -- | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | -- | -- |
| Current Assets | Other Current Assets | 358.0K | 840.0K | 3.7M | -- | |
| Current Assets | 17.3M | 91.4M | 151.5M | -- | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | -- | 234.0K | -- | |
| Depreciation | -- | -- | -29.0K | -- | ||
| Other Assets | 0.00 | 772.0K | 187.0K | -- | ||
| Total Assets | 17.3M | 92.1M | 151.9M | -- | ||
| Liabilities | Accounts Payable | 0.00 | 0.00 | 5.9M | -- | |
| Accrued Expenses | 424.0K | 1.2M | 2.1M | -- | ||
| Other Current Liabilities | 2.7M | 7.1M | 2.1M | -- | ||
| Other Liabilities | 3.0M | 7.9M | 9.1M | -- | ||
| Total Liabilities | Other Liabilities | 2.2M | 2.1M | 2.3M | -- | |
| Total Liabilities | 5.2M | 10.0M | 11.4M | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Equity | 12.1M | 82.2M | 140.5M | -- | ||
| Total Shareholder Equity | 12.1M | 82.2M | 140.5M | -- | ||
| Share Information | Common Shares Outstanding | 34.2M | 34.2M | 34.2M | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
